TARSUS PHARMACEUTICALS INC.
■ FOUNDED: 2016
■ CEO: Bobak Azamian
■ HEADQUARTERS: Irvine
■ BUSINESS: pharmaceuticals, therapeutics
■ Q1 LOSS: 98 cents per share
(vs. expected 87-cent loss)
■ EMPLOYEES: 46
■ NOTABLE: raised $75.6M in an oversubscribed public offering; submitting a New Drug Application to the FDA this year
HEALTHCARE
en-us
2022-05-23T07:00:00.0000000Z
2022-05-23T07:00:00.0000000Z
https://ocbusinessjournal.pressreader.com/article/281814287474794
LABJ